Ongoing pain despite aggressive opioid pain management among persons with HIV

John Koeppe1, Carl Armon, Karen Lyda

  • 1Division of Infectious Diseases, Departments of Medicine, University of Colorado Denver, Aurora, CO 80045, USA. john.koeppe@uchsc.edu

Insights

Opioid use for chronic pain in people with HIV is linked to psychosocial factors and a history of AIDS. Patients on opioids still report higher pain levels, indicating limited efficacy.

Area of Science:

  • Pain Management
  • Infectious Diseases
  • Public Health

Background:

  • Chronic pain is prevalent in individuals with Human Immunodeficiency Virus (HIV).
  • Opioids are commonly prescribed for managing chronic pain in this population.
  • Limited data exist on factors influencing opioid use and its effectiveness in HIV patients.

Purpose of the Study:

  • To investigate variables associated with opioid use for chronic pain in persons with HIV.
  • To assess the efficacy of opioid therapy in managing chronic pain among HIV-positive individuals.

Main Methods:

  • A cross-sectional cohort study was conducted in 2005.
  • Patients were categorized into three groups: daily opioid therapy for chronic pain, chronic pain without daily opioids, and no chronic pain diagnosis.
  • Self-reported pain data were collected and analyzed.

Main Results:

  • Opioid users were more likely to use benzodiazepines/gamma-aminobutyric receptor agonists, have a history of injection drug use, lack private insurance, report abuse, have a history of AIDS, and attend appointments more frequently.
  • Patients on opioid therapy reported significantly higher pain scores (4.3 vs. 1.9 vs. 0.7) and greater pain severity (58.6% vs. 15.5% vs. 4.9%).

Conclusions:

  • Psychosocial factors and a history of AIDS are associated with opioid prescribing in HIV patients.
  • Opioid therapy did not resolve pain, as patients on these medications continued to report higher pain levels.
Abstract

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...